ChemPartner’s phage display and high throughput screening group offers streamlined services for fully human therapeutic antibody discovery and optimization, also providing coherent protein engineering, immune library construction, and screening for general biologics...
ChemPartner’s antibody engineering team performs antibody sequencing and chimeric antibody generation routinely. Supported by an elite protein structure team in modeling area, we are able to do hotspot analysis and removal, world-class humanization design with...
ChemPartner’s hybridoma group provides premium monoclonal antibody services with our advanced hybridoma platform, which has been validated by more than 100 integrated therapeutic projects and a large number of reagent mAb projects. A number of key technologies are...
ChemPartner’s antibody discovery team has over 200 scientists, 30 of which are PhDs or MDs. Our scientists are capable of discovering novel high-affinity monoclonal antibodies by hybridoma technology, B cell cloning technology and phage display technology. We can also...
